Objective: the protective effects of a novel stilbene derivative, (e)-2-(3,4,5-trimethoxystyryl)-3,5,6-trimethylpyrazine (MStMp), on hydrogen peroxide (h 2 o 2 )-induced human derived neuroblastoma cell (Sh-Sy5y) damage and its molecular mechanisms were investigated. Methods: Sh-Sy5y cells were exposed to 200 μmol . l -1 h 2 o 2 for 12 h. the effect of MStMp on cell viability and apoptosis was assessed by 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (Mtt) assay and flow cytometry method. the activities of lactate dehydrogenase (ldh), superoxide dismutase (Sod) and nitric oxide synthetase (noS) and the content of malondialdehyde (Mda), reduced glutathione (gSh) and nitric oxide (no) in cells were determined by commercial kits. the expressions of pro-apoptotic factor caspase-3, caspase-9 and inducible noS (inoS) were detected by Western blotting. intracellular formation of reactive oxygen species (roS) was assessed using 6-carboxy-2',7'-dichlorofluorescin diacetate (dCfh-da) fluorescent probe. Results: MStMp increased the Sh-Sy5y cell viability by inhibition of cell apoptosis induced by h 2 o 2 . these effects were accompanied by an increase of Sod activity, gSh level, and a decrease of Mda content. Moreover, MStMp showed stronger effects on inhibition of ldh leakage, apoptotic cells, intracellular roS level and the expression of caspase-3 and caspase-9 than tMp. furthermore, MStMp induced a decrease of no level and the activity of inoS, tnoS in a time-dependent manner. Conclusions: MStMp prevents h 2 o 2 -induced cell injury through anti-oxidation and anti-apoptosis via roS-no pathway.
INTRODUCTION
oxidative stress on neuronal cells, characterized by an imbalance in the cellular activity related to the production and elimination of reactive oxygen species (roS), is involved in the pathophysiology of neurodegenerative diseases, such as alzheimer's disease (ad), vascular dementia (vd) and cerebral ischemia 1 . in ad patients, who are highly sensitivity to roS, accumulated intracellular oxygen free radicals induce membrane lipid peroxidation, dna structure damage, and even damage of the fluidity and permeability of cell membranes 2, 3 . reactive oxygen species can also induce apoptosis by triggering numerous signaling transduction pathways, including members of the mitogen-activated protein kinase (MapK) family, p53 transcription factors and caspase-3 activation 4 . therefore, anti-oxidants and anti-apoptotic agents are promising candidates myocardial and cerebral ischemic diseases because of its effectiveness and low toxicity 6, 7 . however, pharmacokinetic studies have shown that tMp presents low bioavailability and is metabolized quickly in vivo with a short half-life of 2.89 hours (h) 8 . furthermore, accumulating toxicity was shown in patients when tMp is administrated frequently in order to maintain effective plasma concentrations 9 . therefore, it is necessary to develop new generations of cerebral-cardio-vascular medicines via the molecular modification of tMp. tetramethylpyrazine stilbene derivatives were produced by replacing the methyl group of tMp molecule with the pharmacophore of resveratrol (reS) (-styryl) by hybridization and bioisosteric replacement. resveratrol has been shown to benefit several human disease models, including neuro-and cardio-protection, immune regulation and cancer chemoprevention. apoptotic and antioxidant mechanisms are the main targets of reS for its broad spectrum of actions [10] [11] [12] . We designed and synthesized these analogues in order to improve the pharmacodynamic and pharmacokinetic properties of tMp and reS. our previous study showed that the tMp stilbene derivative CStMp exhibited stronger anti-oxidation and anti-apoptosis effects on human endothelial cells than tMp and reS 13 . We further screened the protective effects of these tMp analogues against oxidative stress in nerve cells. results showed that (e)-2-(3,4,5-trimethoxystyryl)-3,5,6-trimethyl-pyrazine (MStMp) showed more potential protection.
in the present study, we used human derived neuroblastoma cells (Sh-Sy5y) to investigate the neuroprotective effect of MStMp (figure 1a), against oxidation injury induced by hydrogen peroxide (h 2 o 2 ) and the underlying mechanism.
MATERIALS AND METHODS

Materials
the stilbene derivative MStMp was synthesized by the institute of Medical Chemistry of Shandong university. dulbecco's modified eagle's medium (dMeM) were purchased from giBCo Brl (grand island, ny, uSa). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (Mtt), dimethyl sulfoxide (dMSo), 6-carboxy-2',7'-dichlorofluorescin diacetate (dCfh-da), annexin v fluorescein isothiocyanate (annexin vfitC) and propidium iodide (pi) were purchased from Sigma (St. louis, Mo, uSa). thirty percent (30%) h 2 o 2 solution was obtained from Wako (osaka, Japan). antibodies against caspase-3, caspase-9, β-actin, and inducible nitric oxide synthetase (inoS) were purchased from Cell Signaling technology (Boston, Ma, uSa). Biotinylated goat anti-rabbit immunoglobin g (igg) and nitrocellulose membranes were purchased from amersham (Buckinghamshire, uK). the lumiglo reserve Chemiluminescent Substrate Kit was purchased from Kpl (gaithersburg, Md, uSa). the lactate dehydrogenase (ldh), superoxide dismutase (Sod), reduced glutathione (gSh), malondialdehyde (Mda), total nitric oxide synthetase (tnoS), inoS and nitric oxide (no) detection kits were purchased from the nanjing Jiancheng Bioengineering institute (nanjing, pr China). all other chemicals used were of analytical grade and obtained from Shanghai Sangon Biological engineering technology & Sciences Co. ltd. (Shanghai, China).
Cell culture and treatment
human derived neuroblastoma cells (Sh-Sy5y) were cultured in dMeM supplemented with 10% (v/v) heatinactivated fetal bovine serum, 100 u/ml penicillin and 100 μg/ml streptomycin in a humidified atmosphere of 5% Co 2 /95% air at 37°C.
for all experiments, cells were used at passages 3 to 6 and seeded at a concentration of 4×10 4 cells/ml on 96-well plates and 7.5×10 4 cells/ml on 6-well plates. MStMp or tMp was freshly prepared as stock solution in dMSo, and diluted with dMeM supplement (0.1% (v/v) dMSo). dMSo was present at equal concentrations (0.03%) in all groups. the h 2 o 2 was freshly prepared before each experiment. Cells were pretreated with MStMp or tMp at 12.5~200 μmol . l -1 for 30 minutes (min), then exposed to h 2 o 2 (200 μmol . l -1 ) for 6 h or 12 h.
Measurement of cell viability by MTT assay
Cell viability was measured by Mtt assay. Briefly, cells were seeded at a concentration of 4×10 4 cells/ml in 96-well plates. after pretreated with MStMp or tMp at 12.5~200 μmol . l -1 for 30 min before exposure to h 2 o 2 for 12h, 20 μl Mtt solution was added to each well at a final concentration of 0.5 mg . ml -1 . after 4 h incubation, 200 μl dMSo was added to each well, and then the optical density was read with a microtiter plate reader (Spectra rainbow, tecan, austria) at a wavelength of 570 nm. Cells pretreated 0.03% dMSo solution for 30 min before exposure to h 2 o 2 for 12h was used as a negative control. 
Detection of cellular LDH release
Sh-Sy5y cells were pretreated with MStMp or tMp at 12.5~200 μmol . l -1 for 30 min, and then stimulated with h 2 o 2 (200 μmol . l -1 ) for 12 h. Cellular ldh release into the culture supernatants was measured using a commercially available kit according to the manufacture's protocol. to determine the intracellular ldh activity, cells were lysed with lysis buffer (150 mmol . l -1 naC1, 150 mmol . l -1 tris-hCl, 1 mmol . l -1 edta, 1% triton X-100). the supernatants were obtained by centrifugation at 13,000 rpm (12100×g) at 4°C for 15 min. ldh release (%) = (ldh activity in supernatants) / (ldh activity in supernatants + ldh activity in total cells) ×100% 14 .
Detection of intracellular MDA and NO content and enzymes activity
Sh-Sy5y cells were pretreated with MStMp at 12. . protein concentrations of cell extracts were determined by the bicinchonininc acid (BCa) assay (hyclone-pierce, South logan, uSa). Cell lysates were collected and used for determination of the Mda, gSh and no contents and enzymatic activities, including Sod, tnoS and inoS using commercial kits.
Measurement of cellular ROS
intracellular formation of roS was assessed as described previously using the oxidation sensitive dye dCfh-da as the substrate 15 . Briefly, Sh-Sy5y cells were treated with MStMp at 25, 50, 100 μmol . l -1 , or 50 μmol . l -1 tetramethylpyrazine for 30 min, and then stimulated with h 2 o 2 (200 μmol . l -1 ) for 12 h. after washing with pBS, 20 μmol . l -1 dCfh-da was introduced in dark for 30 min at 37°C. then cells were washed with pBS twice to remove extracellular dCfh-da. the formation of 2',7'-dichlorofluorescin (dCf) due to oxidation of dCfh in the presence of various roS was measured with a viCtor Wallac 1420 Multilabel Counter (perkin elmer life Science, uSa) (ex=485 nm, em=538 nm).
Determination of cell apoptosis by Flow cytometry
early apoptosis and late apoptosis/necrosis of Sh-Sy5y cells induced by h 2 o 2 were detected quantitatively by flow cytometric analysis using annexinv and pi 16 . Cells were harvested by non-enzymatic cell dissociation and centrifugation (120 × g, 5 min, 4°C) to remove the medium. the cells were washed three times with binding buffer (10 mmol . l -1 hepes, 140 mmol . l -1 naCl, 2.5 mmol . l -1 CaCl 2 ) and stained with 20 μg . ml -1 annexin v-fitC for 30 min and then incubated with pi (final concentration, 3.7 μmol . l -1 ) for 10 min. annexin v and pi emissions were detected in the fl1-h and fl2-h channels of a faCSvantage flow cytometer (Becton dickinson immunocytometry System, San Jose, Ca, uSa), using emission filters of 525 and 575 nm, respectively.
Measurement of the expression of caspase-3, caspase-9 and iNOS using Western blotting analysis
after treatment with 50 μmol . l -1 MStMp or 50 μmol . l -1 tMp, confluent monolayers of the Sh-Sy5y cells in 6-well plates were washed twice with ice-cold pBS and lysed with extraction buffer. the protein concentrations of the cell extracts were determined by the BCa assay. total cell lysate was subjected to Sodium dodecyl sulfate (SdS)-polyacrylamide gel electrophoresis (page), transferred to a nitrocellulose membrane, and incubated with monoclonal antibodies against caspase-3, caspase-9 or β-actin or polyclonal antibody against inoS. immunoblots were developed using horseradish peroxidase-conjugated secondary antibodies 17 . immunoreactive bands were visualized by enhanced chemiluminescent (eCl) system (amersham pharmacia Biotech, piscataway, nJ, uSa) and quantified by densitometry using a Chemidoc XrS (Biorad, Berkeley, Califonia, uSa). the density of each band was normalized by β-actin for their respective lanes.
Statistical analysis
the results are expressed as means ± S.d. of three independent experiments. Statistical comparisons were performed by analysis of variance (anova) followed by tukey's test. a probability value <0.05 was considered significant. 
RESULTS
MSTMP increases SH-SY5Y cells survival in cell
MSTMP inhibits apoptosis induced by H 2 O 2
the cytoprotective action of MStMp on apoptosis induced by h 2 o 2 was evaluated by flow cytometric analysis using the annexin v-fitC cell surface binding. in this assay, the cell population of annexin v -/pi -was normal healthy cells, while the annexin v + /pi -cells were early apoptotic cells and annexin v + /pi + were necrosis/late apoptotic cells. typical examples of the assessments are shown in figure 2a-f. We found that 4.7% of cells in the control group showed early and late apoptosis. an increase of apoptotic cells was observed in the h 2 o 2 -treated group. MStMp treatment led to a decrease in the rate of early apoptosis and necrosis/late apoptosis in cells exposed to h 2 o 2 . this effect of MStMp was observed in a dose-dependent manner (figure 2g).
MSTMP inhibits caspase-3, caspase-9 expression in apoptotic SH-SY5Y cells induced by H 2 O 2
to test whether MStMp affected the expression of caspase-3 and caspase-9, the apoptosis marker, specific antibodies against caspase-3 and caspase-9 were used for Western blotting assay. in cells exposed to h 2 o 2 for 24 h, expression of caspase-3 and caspase-9 was significantly enhanced. however, in h 2 o 2 -exposed cells treated with MStMp at concentrations of 50 μmol . l -1 and 50 μmol . l -1 tMp, the increased expression of caspase-3 and caspase-9 was inhibited ( figure 3 ). these results demonstrate that MStMp could prevent oxidant-induced apoptosis through inhibition of caspase-3 and caspase-9 activation. 
MSTMP decreases lipid peroxidation and increases
MSTMP inhibits the cellular production of ROS
the production of roS in Sh-Sy5y cells in response to h 2 o 2 was examined using the fluorescence probe dCf. We found that h 2 o 2 treatment resulted in an increase in dCf fluorescence intensity compared with cells treated with cultured medium only (figure 4). the increase in the dCf signal was suppressed by pretreatment of the cells with 25, 50 or 100 μmol . l -1 MStMp or 50 μmol . l -1 tMp. these results indicate that MStMp effectively inhibited the production of total cellular roS.
MSTMP inhibits NO production, iNOS/tNOS activities and iNOS expression in SH-SY5Y cells in response to H 2 O 2
the no production in cells was increased and reached its peak at 24 h, then decreased gradually. the presence of MStMp (at 50 μmol . l -1 ) for 6 h to 48 h significantly reduced the cellular content of no (figure 5a). h 2 o 2 treatment also increased the cellular activities of inoS/tnoS. the presence of MStMp (at 50 μmol . l -1 ) and tMp (at 50 μmol . l -1 ) decreased the activity of inoS and tnoS, the expression of inoS induced by h 2 o 2 (figure 5B, 5C and 5d). Moreover, 50 μmol . l -1 MStMp showed better inhibition of both no content and inoS/tnoS activity than tMp.
DISCUSSION
reactive oxygen species often caused accelerated aging and chronic diseases, including neurodegenerative diseases and inflammation, by inducing oxidative damage in biomolecules, such as carbohydrates, proteins, lipids, and dna 18 . hydrogen peroxide is a well-known roS that is formed during normal metabolism, where it is produced in the brain during the catalytic degradation of neurotransmitters. hydrogen peroxide could form highly reactively and deleterious hydroxyl radicals by the fenton reaction, and partially mediates the toxicity of aβ, the major pathological hallmark for ad 19 . in the present study, we observed that h 2 o 2 could markedly destroy the integrity of ShSy5y cell membranes, as demonstrated by ldh release, and lead to massive apoptosis, as evidenced by flow cytometry. pretreatment of MStMp on the cells effectively protected ShSy5y cells from h 2 o 2 -induced damage through an antioxidative action and from apoptosis through inhibition of the roS-no pathway.
tetramethylpyrazine is one of important therapeutic agents for the treatment of some cerebral and cardiovascular diseases, acting as an antioxidant and by other pharmacological actions 20, 21 . MStMp is a novel stilbene derivative via molecular oxidative metabolites are involved in the functional inactivation of nerve cells due to increased permeability and, additionally, are potent inducers of neuron death. the intracellular Mda level reflects the extent of cell damage by oxidative stress. the endogenous antioxidant enzyme Sod and reductive compound gSh are thought to be crucial for augmentation of antioxidant defenses in cells. Superoxide dismutase can scavenge superoxide radicals by converting them to h 2 o 2 , which is then converted to water by catalase and glutathione peroxidase (gSh-px) 22 . our results showed that MStMp reduced the reduction of the Sod activity and the gSh level and augmented Mda content in Sh-Sy5y cells in response to h 2 o 2 . this suggests that the cytoprotective effect of MStMp was likely related to the restoration of endogenous antioxidation and the decrease of lipid peroxidation.
excessive production of roS in cells can either directly or indirectly lead to mitochondrial dysfunction, apoptosis, and cell death 23 . reactive oxygen species can induce the release of apoptotic factors such as cytochrome C or apoptosis-inducing factor and then stimulate apoptotic-like biochemical caspases. Caspases are a family of cysteine proteases that cleave target proteins at specific residues. among the more than ten members of the caspase family identified, caspase-3 and caspase-9 are major players in apoptosis induced by oxidative stress 24, 25 . this study investigated the effects of MStMp on the apoptosis rate and related protein expression. results showed that the presence of MStMp decreased intracellular roS generation and reduced Sh-Sy5y cell apoptosis by inhibition of the expression of caspase-3 and caspase-9.
Some evidence has suggested that abnormal regulation of no generation from neuronal nitric oxide synthase (nnoS) and inoS is associated with many neuronal diseases, such as brain ischemia 26 , parkinson's disease (pd) 27 , ad 28 , and amyotrophic lateral sclerosis 29 . under normal conditions, the concentrations of no in brain cells are very low. however, under pathological conditions, the production of roS and no increases and they combine with each other to form the reactant peroxynitrite (onoo -) 30 . Moreover, noS could produce superoxide as well as no in the presence of low arginine levels and that mtnoS could be an onoo -synthase, thereby constituting an alternative source of onoo -in vivo. Both no and onoo -can damage cellular components such as dna and lipids by nitrosylation of proteins and inhibit mitochondrial respiratory chain enzymes and promote mitochondrial depolarization and cell death. in addition, it was reported that the treatment of noS inhibitors could reverse the activation of the caspase cascade 31 . therefore, roS and no possess very important roles in the apoptosis induced by oxidative stress. in this study, MStMp significantly decreased the content of no in Sh-Sy5y cells by inhibiting inoS expression and activity in a time-dependent manner. We also observed that the anti-apoptotic action and inactivation of caspase-3 of MStMp are paralleled by a decrease in no content. these results indicated that MStMp inhibits Sh-Sy5y cell apoptosis induced by h 2 o 2 via a roS-no pathway. furthermore, MStMp shows a greater effect than tMp on inhibiting ldh release, scavenging roS, apoptosis and no production.
in the present study, we used Sh-Sy5y cells to observe the neuroprotection of MStMp against cellular oxidative stress. Sh- Sy5y cells possess typical central nervous system (CnS) characteristics such as neurite-like cytoplasmic processes, the expression of neuronal specific tyrosine hydroxylase, cholinesterase, dopamine β hydroxylase, etc 32 . therefore, this cell line had wide use in the primary studies of drugs on neurodegenerative diseases, such as ad or pd 33 . We will further continue to investigate the neuroprotection of MStMp on primary cultured neurons.
in conclusion, MStMp significantly protected Sh-Sy5y cells against h 2 o 2 damage via anti-oxidative and anti-apoptosis effects. the antioxidant MStMp diminishes the apoptosis of Sh-Sy5y cells by inhibiting the activation of caspase-3 and no synthesis. these findings suggest that MStMp may have important potential for the development of new agents for effective treatment of neurodegenerative diseases.
